img

Global supplementum Environmental Praesidium

Et Salutis Novae Materialis Solutiones

Pharmaceutical Ingrediens API et Pharmaceutical Intermedia

Nos focus in enucleandis et componendis tinib APIs et intermedia cognata.In statu nos API Alectinib, Palbociclib supplere possumus;
Pemigatinib, et diversis intermediis Alectinib, Palbociclib, Pemigatinib, Infigratinib, Rimegapant, Pralsetinib, Sotorasib.


Detail

XII (2)
Nomen Structure CAS Non. Annua output
Alectinib  XII (1) 1256580-46-7 5 kg
 Object 1 1256698-41-5 20 kg
 Object 2 1256584-75-4 50 kg
 Object 3 939-80-0 1800 kg
 Object 4 1256584-73-2 2000 kg
 Object 5 53617-35-9 560 kg
Nomen Structure CAS Non. Annua output
acidum 5-aminoisophthalicum Object 6 13290-96-5 M t
 Object 7 618-88-2 800 t
 Object 8 99-31-0 550 t

Nomen

Structure

CAS Non.

Annua output

Lorlatinib

 Object 9

1454848-24-8

10 kg

 Object 10

1643141-20-1

20 kg

Object 11

1454846-35-5

10 g*

Nomen

Structure

CAS Non.

Annua output

Pemigatinib

 Object 12

958230-19-8

1 kg

 Object 15

651734-54-2

50 kg

Object 14

1513857-77-6

1 g*

Nomen

Structure

CAS Non.

Annua output

Infiguratib

BGJ-398

 Object 15

872509-56-3

10 kg

 Object 16

10272-07-8

50 kg

Nomen

Structure

CAS Non.

Annua output

Rimegepant

Object 17

1373116-06-3

10kg

 Object 18

1190363-46-2

100g

Alia media

Nomen

Structure

CAS Non.

Annua output

   Object 22

364-78-3

2 t

 Object 23

2897-43-0

300 kg

Object 24

3753-18-2

20 t

Relinquere Your Nuntius Your Company

Epistulam tuam hic scribe et mitte nobis

Relinquere Your Message